Ananda Immunotherapies Revenue
Biotechnology Research • 
Singapore, Singapore • 1-10 Employees
$
Ananda Immunotherapies revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Key Contact at Ananda Immunotherapies
Adrian Lim
CEO and Co-founder
Company overview
| Headquarters | Singapore, Singapore |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
About Ananda Immunotherapies
Ananda Immunotherapies is a clinical-stage biotech, developing next-generation therapies focused on immune tolerance.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
C-Suite
Employees by Department
Ananda Immunotherapies has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Ananda Immunotherapies has never raised funding before.
United States
Germany
United Kingdom
Frequently asked questions
Ananda Immunotherapies is located in Singapore, SG.
Ananda Immunotherapies generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.
Ananda Immunotherapies has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Ananda Immunotherapies has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
